Mirion Technologies, Inc. (NYSE:MIR) Shares Bought by T. Rowe Price Investment Management Inc.

T. Rowe Price Investment Management Inc. lifted its holdings in Mirion Technologies, Inc. (NYSE:MIR - Free Report) by 1.1% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 20,388,146 shares of the company's stock after buying an additional 216,258 shares during the quarter. T. Rowe Price Investment Management Inc. owned approximately 8.78% of Mirion Technologies worth $355,774,000 as of its most recent SEC filing.

A number of other hedge funds also recently bought and sold shares of the company. Price T Rowe Associates Inc. MD boosted its stake in Mirion Technologies by 13.7% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 140,276 shares of the company's stock worth $2,448,000 after purchasing an additional 16,910 shares in the last quarter. Greenhouse Funds LLLP bought a new stake in shares of Mirion Technologies in the fourth quarter worth approximately $12,226,000. Tower Research Capital LLC TRC lifted its position in Mirion Technologies by 162.9% during the fourth quarter. Tower Research Capital LLC TRC now owns 6,649 shares of the company's stock valued at $116,000 after purchasing an additional 4,120 shares during the period. MetLife Investment Management LLC grew its position in Mirion Technologies by 5.9% in the 4th quarter. MetLife Investment Management LLC now owns 124,137 shares of the company's stock worth $2,166,000 after purchasing an additional 6,878 shares during the period. Finally, Dimensional Fund Advisors LP grew its position in Mirion Technologies by 2.5% in the 4th quarter. Dimensional Fund Advisors LP now owns 7,185,694 shares of the company's stock worth $125,391,000 after purchasing an additional 171,918 shares during the period. Institutional investors own 78.51% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have commented on MIR shares. B. Riley cut their target price on shares of Mirion Technologies from $19.00 to $17.00 and set a "buy" rating for the company in a research report on Wednesday, April 16th. Robert W. Baird lowered their target price on shares of Mirion Technologies from $22.00 to $20.00 and set an "outperform" rating on the stock in a research note on Friday, April 4th. Finally, Citigroup decreased their price target on shares of Mirion Technologies from $20.00 to $17.00 and set a "buy" rating on the stock in a research note on Monday, April 14th. Four equities research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, Mirion Technologies presently has a consensus rating of "Buy" and an average target price of $18.75.

Mirion Technologies Trading Up 0.4 %

NYSE:MIR traded up $0.07 during mid-day trading on Tuesday, hitting $15.46. 362,531 shares of the stock traded hands, compared to its average volume of 1,673,882. The company has a quick ratio of 1.55, a current ratio of 2.16 and a debt-to-equity ratio of 0.43. The stock has a market capitalization of $3.59 billion, a price-to-earnings ratio of -81.11 and a beta of 0.75. The firm's 50 day moving average is $14.49 and its two-hundred day moving average is $15.64. Mirion Technologies, Inc. has a 52 week low of $9.11 and a 52 week high of $18.81.

Mirion Technologies (NYSE:MIR - Get Free Report) last issued its earnings results on Tuesday, February 11th. The company reported $0.16 earnings per share for the quarter, topping the consensus estimate of $0.14 by $0.02. Mirion Technologies had a positive return on equity of 4.78% and a negative net margin of 4.21%. On average, equities research analysts predict that Mirion Technologies, Inc. will post 0.39 earnings per share for the current year.

About Mirion Technologies

Mirion Technologies, Inc provides radiation detection, measurement, analysis, and monitoring products and services in the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, Netherlands, Estonia, South Korea, and Japan. It operates through two segments, Medical and Technologies.